Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Administered by trained professionals in a clinical setting
Subgroup analyses were conducted according to the type of underlying diseases, type of control, and trial duration
Reported Research Benefits Selective GHS-R1a agonism without ACTH, cortisol, or prolactin elevation confirmed in human pharmacology studies Pulsatile GH release: preserves natural GH secretion rhythm (unlike continuous exogenous HGH) Stacked with CJC-1295 DAC: Teichman 2006 showed 210 GH elevation sustained for 911 days Improved body composition: lean mass gain, fat mass reduction in GH secretagogue literature Sleep quality improvement: GH secretion peaks during slow-wave sleep, enhanced by ipamorelin protocols Shorter half-life (~2 hours) allows dosing flexibility and rapid clearance vs long-acting alternatives Dosing Protocol & Reconstitution Reported Research Dosing Not Clinical Recommendations Ipamorelin is most commonly dosed alongside CJC-1295 because the two peptides hit independent receptors (ghrelin and GHRH) and their GH-releasing effects add together
Simply put, as long as you meet the criteria, it is safe to take this weight-loss medication
Conklin DJ, Haberzettl P, Prough RA, Bhatnagar A: Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke
This usually isn't harmful
